Published in Evid Based Complement Alternat Med on February 25, 2016
Anti-inflammatory effect of Chang-An-Shuan on TNBS-induced experimental colitis in rats. BMC Complement Altern Med (2017) 0.75
Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology (2004) 14.78
Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res (2009) 3.66
Smads as transcriptional co-modulators. Curr Opin Cell Biol (2000) 2.92
Signaling of transforming growth factor-beta family members through Smad proteins. Eur J Biochem (2000) 2.39
Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child (2003) 1.82
Microscopic colitis. Gastroenterology (2011) 1.66
Positive and negative regulation of TGF-beta signaling. J Cell Sci (2000) 1.62
Role of Smads in TGFβ signaling. Cell Tissue Res (2011) 1.62
Nucleocytoplasmic shuttling of Smad proteins. Cell Res (2009) 1.55
An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol (2002) 1.52
An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol (2011) 1.42
Signal transduction in pancreatic stellate cells. J Gastroenterol (2009) 1.36
Review of the activation of TGF-beta in immunity. J Leukoc Biol (2008) 1.35
A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol (2000) 1.31
Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. Br J Cancer (2008) 1.19
Transforming growth factor-β and Smads. Contrib Nephrol (2011) 1.17
Phosphatases in SMAD regulation. FEBS Lett (2012) 1.13
miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis (2013) 1.09
TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice. Gastroenterology (2007) 0.92
TGF-Beta signaling manipulation as potential therapy for IBD. Curr Drug Targets (2013) 0.85